Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

PacBio to Expand MAS-Seq Technology to 16S rRNA and Bulk RNA-Seq Solutions

PR Newswire - Press Release

All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here

End-to-End Solutions Planned to Support Key Customer Applications With Increased Cost Flexibility on Long-Read Sequencing Systems

MENLO PARK, Calif., Feb. 7, 2023 /PRNewswire/ -- PacBio (NASDAQ:PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the commencement of a program intended to expand Multiplexed Arrays Sequencing (MAS-Seq) for new assays on the Sequel II/IIe and Revio™ sequencing systems. This program builds on the successful MAS-Seq concatenation technology launched last year that enabled cost-effective single-cell isoform sequencing.

Read more at prnewswire.com

Related Symbols

Symbol Last Chg %Chg
PACB 2.12 -0.05 -2.30%
Pacific Biosciences

Most Popular News

Intel Corp_ Santa Clara campus-by jejim via Shutterstock 1
Intel Is Reportedly Buying SambaNova Systems. What Does That Mean for INTC Stock?
Businessman touching the brain working of Artificial Intelligence (AI) Automation by Suttiphong Chandaeng via Shutterstock 2
Forget Palantir, This ‘Strong Buy’ AI Stock Beats PLTR on Value
EV in showroom by Robert Way via Shutterstock 3
Why Nio Stock’s Probability Curve Points to a Hidden Upside Setup
A concept image showing a periodic table for rare earth metals by William Potter via Shutterstock 4
USA Rare Earth Just Revved up Its Commercial Timeline. Should You Buy USAR Stock Here?
Doctor holding money by IherPhoto via iStock 5
2 ‘Strong Buy’ Biotech Stocks With 208% to 329% Upside Potential
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot